T-cell recognition of discrete regions of the thrombolytic drug streptokinase

Clinical Science

Volumn 99, Issue 3, 2000, Pages 239-246

  Lawley, W J ^a   Fletcher, S ^a   Squire, I B ^a   Woods, K L ^a   Hewitt, C R A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Immunotherapy; Peptide epitopes; Streptokinase resistance; T cells

Indexed keywords

EPITOPE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; STREPTOKINASE; T LYMPHOCYTE ANTIBODY; COMPLEMENTARY DNA; PEPTIDE FRAGMENT;

ALLERGIC REACTION; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART INFARCTION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOGENICITY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ANALYSIS OF VARIANCE; CELL DIVISION; CELL LINE; CULTURE TECHNIQUE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ANALYSIS OF VARIANCE; BASE SEQUENCE; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; DNA, COMPLEMENTARY; EPITOPES, T-LYMPHOCYTE; FIBRINOLYTIC AGENTS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STREPTOKINASE; T-LYMPHOCYTES;

EID: 0033820860     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0990239     Document Type: Article

References (25)

1. Fibrinolytic activity of hemolytic streptococci. The development of resistance to fibrinolysis following acute hemolytic streptococcus infections
2. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
3. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction
4. The distribution of antibodies to Streptokinase
5. The significance of anti-streptokinase antibodies
6. Use of streptokinase as a recall antigen for lymphocyte proliferation testing in vitro
7. The proliferative T-lymphocyte response to Streptokinase
8. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction
9. Immunology of Streptokinase in human subjects
10. Serum sickness following streptokinase therapy
11. Serum sickness-like illness following streptokinase therapy. A case report
12. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction
13. A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments
14. Identification of a plasminogen binding region in streptokinase that is necessary for the creation of a functional streptokinase-plasminogen activator complex
15. Structural characterization of immunodominant regions of streptokinase recognized by murine monoclonal antibodies
16. At least five antigenic epitopes on the streptokinase molecule are recognized by human CD4+ TCRαβ+ T cells
17. Genetic manipulation of pathogenic streptococci
18. Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A
19. The proliferative response of peripheral blood mononuclear cells to Streptokinase
20. Overlapping T cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules
21. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones
22. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein
23. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis
24. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus
25. Individual risk-assessment for intracranial haemorrhage during thrombolytic therapy